Finance

Lists
GMED:NYSE
Globus Medical Inc
$72.14
-0.18%
(-0.13) 1D
$72.14
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:05 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMED...
Open
$72.75
High
$73.45
Low
$71.72
Mkt. cap
9.56B
Avg. vol.
1.85M
Volume
1.55M
P/E ratio
17.72
52-wk high
$101.40
52-wk low
$70.40
EPS
$4.07
Beta
0.98
Shares outstanding
110.04M
No. of employees
6K
Open
$72.75
High
$73.45
Low
$71.72
Mkt. cap
9.56B
Avg. vol.
1.85M
Volume
1.55M
P/E ratio
17.72
52-wk high
$101.40
52-wk low
$70.40
EPS
$4.07
Beta
0.98
Shares outstanding
110.04M
No. of employees
6K
News stories
From web sources and news partners
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc
CEOKeith Pfeil
Employees6K
Founded2003
Headquarters-
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 10 analysts giving stock ratings to GMED in the past 3 months
Buy
Buy
6
Hold
4
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for GMED in the last 3 months.
Highest
Current $72.14
$105.00 (+45.55%)
Average
$91.25 (+26.49%)
Lowest
$78.00 (+8.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
11/06/2026
Richard Newitter
Truist Financial
Buy
Reiterated
$90.00
+24.8%
11/06/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$100.00
+38.6%
11/06/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$100.00
+38.6%
11/06/2026
Kendall Au
RBC Capital
Buy
Reiterated
$85.00
+17.8%
11/05/2026
Caitlin Cronin
Canaccord Genuity
Buy
Maintained
$105.00
+45.6%
11/06/2026
Vik Chopra
BMO Capital
Hold
Downgraded
$78.00
+8.1%
11/06/2026
Thomas Stephan
Stifel Nicolaus
Hold
Reiterated
$85.00
+17.8%
10/07/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
$85.00
+17.8%
10/01/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
09/18/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
$115.00
+59.4%
08/28/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
$87.00
+20.6%
08/27/2026
David Saxon
Needham
Buy
Reiterated
$117.00
+62.2%
08/07/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
$115.00
+59.4%
08/06/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$115.00
+59.4%
08/06/2026
Unknown Analyst
UBS
Hold
Initiated
$82.00
+13.7%
07/28/2026
Patrick Wood
UBS
Hold
Initiated
$82.00
+13.7%
07/28/2026
Unknown Analyst
BMO Capital
Buy
Initiated
$94.00
+30.3%
07/09/2026
Matt Miksic
Barclays
Buy
Maintained
$123.00
+70.5%
05/11/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$1.23 / $1.20
+2.77%beat
Revenue / Est. (USD)
763.72M / 792.46M
-3.63%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
826.42M
759.85M
789.61M
763.72M
Cost of goods sold
254.62M
234.07M
241.44M
232.92M
Cost of revenue
254.62M
234.07M
241.44M
232.92M
Research and development expenses
36.16M
36.51M
36.32M
34.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
304.78M
297.77M
286.76M
284.81M
Operating expense
370.30M
363.81M
352.64M
348.91M
Total operating expenses
624.93M
597.87M
594.08M
581.83M
Operating income
201.49M
161.98M
195.53M
181.89M
Other non operating income
865.00K
2.25M
1.17M
-982.00K
EBT including unusual items
169.23M
157.07M
189.82M
183.27M
EBT excluding unusual items
198.52M
167.55M
202.92M
187.61M
Income tax expense
28.64M
32.77M
38.25M
42.10M
Effective tax rate
16.92%
20.86%
20.15%
22.97%
Other operating expenses
-
-
-
-
Net income
140.59M
124.30M
151.57M
141.17M
Net profit margin
17.01%
16.36%
19.20%
18.48%
Earnings per share
1.28
1.12
1.34
1.23
Interest and investment income
3.31M
5.43M
7.07M
8.41M
Interest expense
-
-
-
-
Net interest expenses
3.31M
5.43M
7.07M
8.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
270.31M
231.93M
265.11M
252.09M
Gain or loss from assets sale
4.09M
2.45M
3.11M
1.21M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps